Compounds > masoprocol

masoprocol and Cancer of Prostate

masoprocol has been researched along with Cancer of Prostate in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (12.50)18.2507
2000's4 (50.00)29.6817
2010's3 (37.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Duan, J; Fan, S; Li, X; Li, Y; Pan, X; Pan, Y; Shi, Y; Tie, L; Wang, X; Xiaokaiti, Y1
Gao, P; Guan, L; Zheng, J1
Fong, L; Formaker, CG; Friedlander, TW; Harzstark, AL; Huang, Y; Lin, AM; Mi, JT; Ryan, CJ; Small, EJ; Weinberg, VK1
Chang, HT; Chen, JS; Chen, WC; Cheng, HH; Hsu, SS; Huang, CJ; Huang, JK; Jan, CR; Jiann, BP1
Chen, Y; Guo, Y; Honn, KV; Jin, R; Krishnamoorthy, S; Milanini, J; Nie, D; Pages, G; Qiao, Y; Tang, K; Zacharek, A1
Claros, C; Goldfine, ID; Harzstark, AH; Kerner, JF; Lin, A; Rosenberg, J; Ryan, CJ; Small, EJ; Youngren, JF1
Allan, G; Campbell, M; Diamond, M; Goldfine, ID; Jones, J; Maddux, BA; Ryan, CJ; Shiry, L; Youngren, JF; Zavodovskaya, M1
Ghosh, J; Myers, CE1

Trials

1 trial(s) available for masoprocol and Cancer of Prostate

ArticleYear
A phase II study of insulin-like growth factor receptor inhibition with nordihydroguaiaretic acid in men with non-metastatic hormone-sensitive prostate cancer.
    Oncology reports, 2012, Volume: 27, Issue:1

    Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Agents; Humans; Male; Masoprocol; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Somatomedin

2012

Other Studies

7 other study(ies) available for masoprocol and Cancer of Prostate

ArticleYear
Nordihydroguaiaretic acid impairs prostate cancer cell migration and tumor metastasis by suppressing neuropilin 1.
    Oncotarget, 2016, Dec-27, Volume: 7, Issue:52

    Topics: Animals; Cell Adhesion; Cell Line, Tumor; Cell Movement; Endothelial Cells; Fibroblasts; Focal Adhesion Protein-Tyrosine Kinases; Humans; Male; Masoprocol; Mice; Neoplasm Metastasis; Neuropilin-1; Prostatic Neoplasms

2016
Role of leukotriene B4 in celecoxib-mediated anticancer effect.
    Biochemical and biophysical research communications, 2010, Nov-12, Volume: 402, Issue:2

    Topics: Antineoplastic Agents; Celecoxib; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colonic Neoplasms; Cyclooxygenase 2 Inhibitors; Humans; Leukotriene B4; Lipoxygenase Inhibitors; Male; Masoprocol; Prostatic Neoplasms; Pyrazoles; Sulfonamides

2010
Nordihydroguaiaretic acid-induced Ca2+ handling and cytotoxicity in human prostate cancer cells.
    Life sciences, 2004, Sep-24, Volume: 75, Issue:19

    Topics: Antineoplastic Agents; Calcium; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Division; Cell Line, Tumor; Cell Survival; Colorimetry; Fluorescent Dyes; Fura-2; Humans; Lipoxygenase Inhibitors; Male; Masoprocol; Prostatic Neoplasms; Solutions; Type C Phospholipases

2004
Mechanisms regulating tumor angiogenesis by 12-lipoxygenase in prostate cancer cells.
    The Journal of biological chemistry, 2006, Jul-07, Volume: 281, Issue:27

    Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Arachidonate 12-Lipoxygenase; Cell Line, Tumor; Cell Movement; Chromones; Endothelium, Vascular; Flavanones; Gene Expression Regulation, Neoplastic; Humans; Lipoxygenase Inhibitors; Male; Masoprocol; Morpholines; Neovascularization, Pathologic; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Promoter Regions, Genetic; Prostatic Neoplasms; Vascular Endothelial Growth Factor A

2006
A pilot dose-escalation study of the effects of nordihydroguareacetic acid on hormone and prostate specific antigen levels in patients with relapsed prostate cancer.
    BJU international, 2008, Volume: 101, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Dose-Response Relationship, Drug; Humans; Male; Masoprocol; Middle Aged; Neoplasm Recurrence, Local; Pilot Projects; Prostate-Specific Antigen; Prostatic Neoplasms; Receptor, IGF Type 1; Treatment Outcome

2008
Inhibitory effects of nordihydroguaiaretic acid (NDGA) on the IGF-1 receptor and androgen dependent growth of LAPC-4 prostate cancer cells.
    The Prostate, 2008, Aug-01, Volume: 68, Issue:11

    Topics: Antioxidants; Cell Division; Cell Line, Tumor; Dihydrotestosterone; Dose-Response Relationship, Drug; Drug Interactions; Gene Expression Regulation, Neoplastic; Humans; Male; Masoprocol; Phosphorylation; Prostatic Neoplasms; Protein Conformation; Receptor, IGF Type 1; Receptors, Androgen; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger

2008
Arachidonic acid stimulates prostate cancer cell growth: critical role of 5-lipoxygenase.
    Biochemical and biophysical research communications, 1997, Jun-18, Volume: 235, Issue:2

    Topics: Arachidonate 5-Lipoxygenase; Arachidonic Acid; Arachidonic Acids; Benzoquinones; Cell Division; Cyclooxygenase Inhibitors; Eicosanoids; Enzyme Inhibitors; Flavanones; Flavonoids; Humans; Hydroxyeicosatetraenoic Acids; Ibuprofen; Indoles; Lipoxygenase Inhibitors; Male; Masoprocol; Proadifen; Prostatic Neoplasms; Tumor Cells, Cultured

1997